Carlo Gambacorti-Passerini

From WikiMD.org
Jump to navigation Jump to search

Carlo Gambacorti-Passerini

Carlo Gambacorti-Passerini (pronunciation: /ˈkɑːrloʊ ˌɡæmbəˈkɔːrti pæsəˈrini/) is an Italian oncologist and researcher known for his significant contributions to the field of cancer research, particularly in the study of chronic myeloid leukemia (CML).

Etymology

The name Carlo is of Italian origin, derived from the Germanic name Karl, meaning "free man". Gambacorti is a surname of Italian origin, while Passerini is a patronymic surname derived from the given name Passero, meaning "sparrow" in Italian.

Career

Carlo Gambacorti-Passerini is a professor of hematology at the University of Milano Bicocca in Milan, Italy. He is also the director of the Department of Oncology and Hemato-Oncology at the same university. His research primarily focuses on the molecular mechanisms of tyrosine kinase inhibitors (TKIs) in the treatment of chronic myeloid leukemia.

Contributions

Gambacorti-Passerini has made significant contributions to the understanding of the molecular mechanisms of tyrosine kinase inhibitors and their role in the treatment of chronic myeloid leukemia. His research has led to the development of new therapeutic strategies for patients with this type of cancer.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski